Tom P. Aufderheide
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tom P. Aufderheide has a total of 199 co-authors. Here are the top co-authors by number of shared publications:
- Ahamed H. Idris
University of Texas Southwestern Medical Center
10 shared publications - Mohamud Ramzan Daya
Department of Emergency Medicine, Oregon Health & Science University
9 shared publications - Graham Nichol
University of Washington-Harborview Center for Prehospital Emergency Care, Seattle, WA, United States
8 shared publications - Henry E. Wang
Department of Emergency Medicine, College of Medicine, The Ohio State University
7 shared publications - Ashish R. Panchal
National Registry of Emergency Medical Technicians
6 shared publications - Michelle Nassal
Department of Emergency Medicine, The Ohio State University, Columbus, OH, United States
6 shared publications
Latest Publications
- Open Access
- 18 May 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (2) , 88-95
Resuscitation From Out-of-Hospital Cardiac Arrest When Is EtCO 2 Reliably Associated With ROSC?
BACKGROUND: Exhaled end-tidal carbon dioxide (EtCO 2 ) trajectory is associated with out-of-hospital cardiac arrest (OHCA) outcomes. However, the minimum EtCO 2 monitoring duration needed to discriminate return of spontaneous circulation (ROSC) from non-ROSC remains unknown. We sought to determine the EtCO 2 trajectory observation time required to differentiate ROSC from non-ROSC patients. METHODS: We performed a secondary analysis of the cluster-randomized Pragmatic Airway Resuscitation Trial (PART), which assessed endotracheal intubation or laryngeal tube strategies in OHCA resuscitation. We summarized mean EtCO 2 in 1-minute epochs over the resuscitation. Cases were stratified a priori by: (1) witnessed versus unwitnessed status, and (2) initial EtCO 2 : low (≤30 mm Hg), moderate (31–49), and high (≥50). Within each stratum, group-based trajectory modeling (GBTM) was used to identify latent EtCO 2 trajectory classes, and patients were categorized into an upward or downward trajectory. To balance trajectory groups on baseline characteristics including age, sex, race, initial rhythm, location, and bystander CPR, we applied inverse probability of treatment weighting. We fit weighted pooled logistic regression models to estimate risk ratios (RRs) for ROSC comparing upward versus downward EtCO 2 trajectories. Within each stratum, we identified the earliest minute when CIs between upward versus downward EtCO 2 trajectories no longer overlapped. RESULTS: EtCO 2 data were available for 1168 patients: 452 (38.6%) witnessed and 716 (61.1%) unwitnessed. Patients were predominantly men (63.5%), with a median age of 65 years (Q1, Q3: 53–75), majority White race (51.3%), and presenting in a nonpublic setting (85.4%). Overall ROSC was 18.2%: 30.5% of witnessed and 10.5% of unwitnessed. Among witnessed arrests, 95% CI for upward versus downward EtCO 2 trajectories no longer overlapped at 8 minutes for low initial EtCO 2 (RR, 3.06; 95% CI, 1.49, 6.71), 12 minutes for moderate EtCO 2 (RR, 1.95; 95% CI, 1.23, 3.48), and 21 minutes for high EtCO 2 (RR, 2.12; 95% CI, 1.30, 3.73). Among unwitnessed arrests, nonoverlapping CIs were first observed at 7 minutes (RR, 3.56; 95% CI, 1.53, 10.37). CONCLUSIONS: Depending on witness status and initial EtCO 2 , between 7 and 21 minutes of monitoring are needed to reliably differentiate upward from downward EtCO 2 trajectories during OHCA resuscitation. Dynamic EtCO 2 trajectory monitoring may provide early prognostic information to guide resuscitation.
- 18 May 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (2) , 88-95
Open AccessResuscitation From Out-of-Hospital Cardiac Arrest When Is EtCO 2 Reliably Associated With ROSC?
BACKGROUND: Exhaled end-tidal carbon dioxide (EtCO 2 ) trajectory is associated with out-of-hospital cardiac arrest (OHCA) outcomes. However, the minimum EtCO 2 monitoring duration needed to discriminate return of spontaneous circulation (ROSC) from non-ROSC remains unknown. We sought to determine the EtCO 2 trajectory observation time required to differentiate ROSC from non-ROSC patients. METHODS: We performed a secondary analysis of the cluster-randomized Pragmatic Airway Resuscitation Trial (PART), which assessed endotracheal intubation or laryngeal tube strategies in OHCA resuscitation. We summarized mean EtCO 2 in 1-minute epochs over the resuscitation. Cases were stratified a priori by: (1) witnessed versus unwitnessed status, and (2) initial EtCO 2 : low (≤30 mm Hg), moderate (31–49), and high (≥50). Within each stratum, group-based trajectory modeling (GBTM) was used to identify latent EtCO 2 trajectory classes, and patients were categorized into an upward or downward trajectory. To balance trajectory groups on baseline characteristics including age, sex, race, initial rhythm, location, and bystander CPR, we applied inverse probability of treatment weighting. We fit weighted pooled logistic regression models to estimate risk ratios (RRs) for ROSC comparing upward versus downward EtCO 2 trajectories. Within each stratum, we identified the earliest minute when CIs between upward versus downward EtCO 2 trajectories no longer overlapped. RESULTS: EtCO 2 data were available for 1168 patients: 452 (38.6%) witnessed and 716 (61.1%) unwitnessed. Patients were predominantly men (63.5%), with a median age of 65 years (Q1, Q3: 53–75), majority White race (51.3%), and presenting in a nonpublic setting (85.4%). Overall ROSC was 18.2%: 30.5% of witnessed and 10.5% of unwitnessed. Among witnessed arrests, 95% CI for upward versus downward EtCO 2 trajectories no longer overlapped at 8 minutes for low initial EtCO 2 (RR, 3.06; 95% CI, 1.49, 6.71), 12 minutes for moderate EtCO 2 (RR, 1.95; 95% CI, 1.23, 3.48), and 21 minutes for high EtCO 2 (RR, 2.12; 95% CI, 1.30, 3.73). Among unwitnessed arrests, nonoverlapping CIs were first observed at 7 minutes (RR, 3.56; 95% CI, 1.53, 10.37). CONCLUSIONS: Depending on witness status and initial EtCO 2 , between 7 and 21 minutes of monitoring are needed to reliably differentiate upward from downward EtCO 2 trajectories during OHCA resuscitation. Dynamic EtCO 2 trajectory monitoring may provide early prognostic information to guide resuscitation.
- Open Access
- 26 June 2025
- Published by Elsevier in Resuscitation Plus
- Vol. 25, 101018
Effect of prehospital advanced airway management on arterial blood gases in the pragmatic airway resuscitation trial
- 26 June 2025
- Published by Elsevier in Resuscitation Plus
- Vol. 25, 101018
Open AccessEffect of prehospital advanced airway management on arterial blood gases in the pragmatic airway resuscitation trial
- 5 March 2025
- Published by Elsevier in Resuscitation
- Vol. 209, 110569
Evaluating the accuracy of surrogate markers for identifying opioid-associated out-of-hospital cardiac arrests
- 5 March 2025
- Published by Elsevier in Resuscitation
- Vol. 209, 110569
Evaluating the accuracy of surrogate markers for identifying opioid-associated out-of-hospital cardiac arrests
- 31 October 2024
- Published by Elsevier in Resuscitation
- Vol. 205, 110422
Vasopressor or advanced airway first in cardiac arrest?
- 31 October 2024
- Published by Elsevier in Resuscitation
- Vol. 205, 110422
Vasopressor or advanced airway first in cardiac arrest?
- Open Access
- 23 July 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-23
Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP): study protocol for a multicenter, randomized, adaptive allocation clinical trial to identify the optimal duration of induced hypothermia for neuroprotection in comatose, adult survivors of after out-of-hospital cardiac arrest
Background: Cardiac arrest is a common and devastating emergency of both the heart and brain. More than 380,000 patients suffer out-of-hospital cardiac arrest annually in the USA. Induced cooling of comatose patients markedly improved neurological and functional outcomes in pivotal randomized clinical trials, but the optimal duration of therapeutic hypothermia has not yet been established. Methods: This study is a multi-center randomized, response-adaptive, duration (dose) finding, comparative effectiveness clinical trial with blinded outcome assessment. We investigate two populations of adult comatose survivors of cardiac arrest to ascertain the shortest duration of cooling that provides the maximum treatment effect. The design is based on a statistical model of response as defined by the primary endpoint, a weighted 90-day mRS (modified Rankin Scale, a measure of neurologic disability), across the treatment arms. Subjects will initially be equally randomized between 12, 24, and 48 h of therapeutic cooling. After the first 200 subjects have been randomized, additional treatment arms between 12 and 48 h will be opened and patients will be allocated, within each initial cardiac rhythm type (shockable or non-shockable), by response adaptive randomization. As the trial continues, shorter and longer duration arms may be opened. A maximum sample size of 1800 subjects is proposed. Secondary objectives are to characterize: the overall safety and adverse events associated with duration of cooling, the effect on neuropsychological outcomes, and the effect on patient-reported quality of life measures. Discussion: In vitro and in vivo studies have shown the neuroprotective effects of therapeutic hypothermia for cardiac arrest. We hypothesize that longer durations of cooling may improve either the proportion of patients that attain a good neurological recovery or may result in better recovery among the proportion already categorized as having a good outcome. If the treatment effect of cooling is increasing across duration, for at least some set of durations, then this provides evidence of the efficacy of cooling itself versus normothermia, even in the absence of a normothermia control arm, confirming previous RCTs for OHCA survivors of shockable rhythms and provides the first prospective controlled evidence of efficacy in those without initial shockable rhythms. Trial registration: ClinicalTrials.gov NCT04217551. Registered on 30 December 2019.
- 23 July 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-23
Open AccessInfluence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP): study protocol for a multicenter, randomized, adaptive allocation clinical trial to identify the optimal duration of induced hypothermia for neuroprotection in comatose, adult survivors of after out-of-hospital cardiac arrest
Background: Cardiac arrest is a common and devastating emergency of both the heart and brain. More than 380,000 patients suffer out-of-hospital cardiac arrest annually in the USA. Induced cooling of comatose patients markedly improved neurological and functional outcomes in pivotal randomized clinical trials, but the optimal duration of therapeutic hypothermia has not yet been established. Methods: This study is a multi-center randomized, response-adaptive, duration (dose) finding, comparative effectiveness clinical trial with blinded outcome assessment. We investigate two populations of adult comatose survivors of cardiac arrest to ascertain the shortest duration of cooling that provides the maximum treatment effect. The design is based on a statistical model of response as defined by the primary endpoint, a weighted 90-day mRS (modified Rankin Scale, a measure of neurologic disability), across the treatment arms. Subjects will initially be equally randomized between 12, 24, and 48 h of therapeutic cooling. After the first 200 subjects have been randomized, additional treatment arms between 12 and 48 h will be opened and patients will be allocated, within each initial cardiac rhythm type (shockable or non-shockable), by response adaptive randomization. As the trial continues, shorter and longer duration arms may be opened. A maximum sample size of 1800 subjects is proposed. Secondary objectives are to characterize: the overall safety and adverse events associated with duration of cooling, the effect on neuropsychological outcomes, and the effect on patient-reported quality of life measures. Discussion: In vitro and in vivo studies have shown the neuroprotective effects of therapeutic hypothermia for cardiac arrest. We hypothesize that longer durations of cooling may improve either the proportion of patients that attain a good neurological recovery or may result in better recovery among the proportion already categorized as having a good outcome. If the treatment effect of cooling is increasing across duration, for at least some set of durations, then this provides evidence of the efficacy of cooling itself versus normothermia, even in the absence of a normothermia control arm, confirming previous RCTs for OHCA survivors of shockable rhythms and provides the first prospective controlled evidence of efficacy in those without initial shockable rhythms. Trial registration: ClinicalTrials.gov NCT04217551. Registered on 30 December 2019.
- 23 December 2022
- Published by Elsevier in Resuscitation
- Vol. 184, 109679
Methods for calculating ventilation rates during resuscitation from out-of-hospital cardiac arrest
- 23 December 2022
- Published by Elsevier in Resuscitation
- Vol. 184, 109679
Methods for calculating ventilation rates during resuscitation from out-of-hospital cardiac arrest
- 5 August 2022
- Published by Elsevier in Resuscitation
- Vol. 179, 50-58
Assessment of intensive care unit-free and ventilator-free days as alternative outcomes in the pragmatic airway resuscitation trial
- 5 August 2022
- Published by Elsevier in Resuscitation
- Vol. 179, 50-58
Assessment of intensive care unit-free and ventilator-free days as alternative outcomes in the pragmatic airway resuscitation trial
- 18 May 2022
- Published by Elsevier in Resuscitation
- Vol. 176, 80-87
Airway strategy and ventilation rates in the pragmatic airway resuscitation trial
- 18 May 2022
- Published by Elsevier in Resuscitation
- Vol. 176, 80-87
Airway strategy and ventilation rates in the pragmatic airway resuscitation trial
- 1 December 2021
- Published by Elsevier in Resuscitation
- Vol. 169, 45-52
Change in out-of-hospital 12-lead ECG diagnostic classification following resuscitation from cardiac arrest
- 1 December 2021
- Published by Elsevier in Resuscitation
- Vol. 169, 45-52
Change in out-of-hospital 12-lead ECG diagnostic classification following resuscitation from cardiac arrest